Raymond James & Associates Viatris Inc Call Options Transaction History

Raymond James & Associates

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 08, 2023	BUY	$8.72 - $11.56 $95,920 - $127,160	11,000 New	11,000 $122,000
Q2 2022 Aug 12, 2022	BUY	$9.95 - $12.27 $157,210 - $193,866	15,800 Added 18.88%	99,500 $27,000
Q1 2022 May 11, 2022	BUY	$9.81 - $15.4 $349,236 - $548,240	35,600 Added 74.01%	83,700 $7,000
Q4 2021 Feb 08, 2022	SELL	$12.09 - $14.68 $345,774 - $419,848	-28,600 Reduced 37.29%	48,100 $48,000
Q3 2021 Nov 02, 2021	BUY	$13.25 - $15.13 $530,000 - $605,200	40,000 Added 108.99%	76,700 $10,000
Q2 2021 Aug 11, 2021	BUY	$12.97 - $16.15 $83,008 - $103,359	6,400 Added 21.12%	36,700 $17,000
Q1 2021 May 14, 2021	BUY	$13.59 - $18.54 $411,777 - $561,762	30,300 New	30,300 $1,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.